Latest Articles

  • Genitourinary manifestations of sickle cell disease
    Surafel Gebreselassie, MD, Matthew N. Simmons, MD, PhD and Drogo K. Montague, MD
    Cleveland Clinic Journal of Medicine October 2015, 82 (10) 679-683; DOI: https://doi.org/10.3949/ccjm.82a.14029

    Sickling can lead to nephropathy, priapism, papillary necrosis, and renal medullary carcinoma.

  • Do healthy patients need routine laboratory testing before elective noncardiac surgery?
    Nathan Houchens, MD, FACP
    Cleveland Clinic Journal of Medicine October 2015, 82 (10) 664-666; DOI: https://doi.org/10.3949/ccjm.82a.14152

    Testing often increases costs and anxiety, with little benefit.

  • A new class of drugs for systolic heart failure: The PARADIGM-HF study
    A new class of drugs for systolic heart failure: The PARADIGM-HF study
    Marwa A. Sabe, MD, MPH, Miriam S. Jacob, MD and David O. Taylor, MD
    Cleveland Clinic Journal of Medicine October 2015, 82 (10) 693-701; DOI: https://doi.org/10.3949/ccjm.82a.14163

    Valsartan-sacubitril is the first new drug in over a decade to decrease death rates in patients with systolic heart failure.

  • GERD: Diagnosing and treating the burn
    Mohammed Alzubaidi, MD and Scott Gabbard, MD
    Cleveland Clinic Journal of Medicine October 2015, 82 (10) 685-692; DOI: https://doi.org/10.3949/ccjm.82a.14138

    If symptoms do not respond to a proton pump inhibitor or are atypical, testing may be needed.

  • In Reply: Resuming anticoagulation after hemorrhage (April 2015)
    Alison Colantino, MD, Amir K. Jaffer, MD, MBA and Daniel J. Brotman, MD
    Cleveland Clinic Journal of Medicine October 2015, 82 (10) 640; DOI: https://doi.org/10.3949/ccjm.82c.10004

    Readers comment on resuming anticoagulation after hemorrhage (April 2015) and on starting insulin therapy in patients with type 2 diabetes (August 2015).

  • What can we offer patients with mild cognitive impairment?
    Tara Horr, MD, Jagan A. Pillai, MBBS, PhD and Barbara J. Messinger-Rapport, MD, PhD
    Cleveland Clinic Journal of Medicine October 2015, 82 (10) 650-652; DOI: https://doi.org/10.3949/ccjm.82a.14130

    Physicians can promote healthy nutrition, physical activity, socialization, and mental activity, but no drug is approved for it.

  • Upper-limb deep vein thrombosis in Paget-Schroetter syndrome
    Nirosshan Thiruchelvam, MD, Farayi Mbuvah, MD, Gaurav Kistangari, MD, MPH and Anil Kumar Reddy Anumandla, MD
    Cleveland Clinic Journal of Medicine October 2015, 82 (10) 658-659; DOI: https://doi.org/10.3949/ccjm.82a.14115

    A weight lifter with no medical history presented with pain and swelling in his left arm.

  • Are breast and pelvic exams necessary when prescribing hormonal contraception?
    Pelin Batur, MD, NCMP, CCD and Abbey B. Berenson, MD, PhD, MMS
    Cleveland Clinic Journal of Medicine October 2015, 82 (10) 661-663; DOI: https://doi.org/10.3949/ccjm.82a.15055

    Only a medical history and blood pressure measurement are needed before prescribing estrogen contraceptives.

  • Starting insulin therapy (August 2015)
    Daniel Weiss, MD
    Cleveland Clinic Journal of Medicine October 2015, 82 (10) 638; DOI: https://doi.org/10.3949/ccjm.82c.10001

    Readers comment on resuming anticoagulation after hemorrhage (April 2015) and on starting insulin therapy in patients with type 2 diabetes (August 2015).

  • In Reply: Starting insulin therapy (August 2015)
    Andre Brateanu, MD, FACP, Giavanna Russo-Alvarez, PharmD, BCACP and Craig Nielsen, MD, FACP
    Cleveland Clinic Journal of Medicine October 2015, 82 (10) 638-639; DOI: https://doi.org/10.3949/ccjm.82c.10002

    Readers comment on resuming anticoagulation after hemorrhage (April 2015) and on starting insulin therapy in patients with type 2 diabetes (August 2015).

Pages